Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles M Perou

Showing results (271-280 of 447) with videos related to

Pageof 45
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2012
Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer modelsPatrick J Roberts, Jerry E Usary, David B Darr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2013
Predicting drug responsiveness in human cancers using genetically engineered miceJerry Usary, Wei Zhao, David Darr, et al.
Breast Cancer Research and Treatment|June 21, 2007
Epidemiology of basal-like breast cancerRobert C Millikan, Beth Newman, Chiu-Kit Tse, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Combination of Polymeric Micelle Formulation of TGFβ Receptor Inhibitors and Paclitaxel Produce Consistent Response Across Different Mouse Models of TNBCNatasha Vinod, Duhyeong Hwang, Sloane Christian Fussell, et al.
Radiology|May 5, 2016
MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene AssaysHui Li, Yitan Zhu, Elizabeth S Burnside, et al.
Science Translational Medicine|June 9, 2017
Combined immune checkpoint blockade as a therapeutic strategy for <i>BRCA1</i>-mutated breast cancerEmma Nolan, Peter Savas, Antonia N Policheni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancerDezheng Huo, Francis Ikpatt, Andrey Khramtsov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinomaTorsten O Nielsen, Forrest D Hsu, Kristin Jensen, et al.
Breast Cancer Research and Treatment|February 26, 2014
Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) culturesKatherine Drews-Elger, Joeli A Brinkman, Philip Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
MYC is amplified in BRCA1-associated breast cancersTatyana A Grushko, James J Dignam, Soma Das, et al.
Pageof 45

Showing results (271-280 of 447) with videos related to

Sort By:
Pageof 45
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2012
Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer modelsPatrick J Roberts, Jerry E Usary, David B Darr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2013
Predicting drug responsiveness in human cancers using genetically engineered miceJerry Usary, Wei Zhao, David Darr, et al.
Breast Cancer Research and Treatment|June 21, 2007
Epidemiology of basal-like breast cancerRobert C Millikan, Beth Newman, Chiu-Kit Tse, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Combination of Polymeric Micelle Formulation of TGFβ Receptor Inhibitors and Paclitaxel Produce Consistent Response Across Different Mouse Models of TNBCNatasha Vinod, Duhyeong Hwang, Sloane Christian Fussell, et al.
Radiology|May 5, 2016
MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene AssaysHui Li, Yitan Zhu, Elizabeth S Burnside, et al.
Science Translational Medicine|June 9, 2017
Combined immune checkpoint blockade as a therapeutic strategy for <i>BRCA1</i>-mutated breast cancerEmma Nolan, Peter Savas, Antonia N Policheni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2009
Population differences in breast cancer: survey in indigenous African women reveals over-representation of triple-negative breast cancerDezheng Huo, Francis Ikpatt, Andrey Khramtsov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinomaTorsten O Nielsen, Forrest D Hsu, Kristin Jensen, et al.
Breast Cancer Research and Treatment|February 26, 2014
Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) culturesKatherine Drews-Elger, Joeli A Brinkman, Philip Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
MYC is amplified in BRCA1-associated breast cancersTatyana A Grushko, James J Dignam, Soma Das, et al.
Pageof 45